Topical anti-inflammatory activity of human recombinant epidermal growth factor

Skin Pharmacology and Applied Skin Physiology

Volumn 12, Issue 1-2, 1999, Pages 79-84

  Casaco Parada A ^a   Ledon N ^b   Gonzalez A ^b   Merino, N ^b   Perez R ^a  

^a CENTER OF MOLECULAR IMMUNOLOGY   (Cuba)

^b NATL CENTER FOR SCIENTIFIC RESEARCH   (Cuba)

Author keywords

12 O tetradecanoylphorbol 13 acetate; Anti inflammatory activity; Arachidonic acid; Croton oil; Epidermal growth factor; Mice; Psoriasis

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIPSORIASIS AGENT; ARACHIDONIC ACID; CROTON OIL; MYELOPEROXIDASE; PHORBOL 13 ACETATE 12 MYRISTATE; RECOMBINANT EPIDERMAL GROWTH FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARACHIDONIC ACID METABOLISM; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; PUNCH BIOPSY; TOPICAL DRUG ADMINISTRATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EAR, EXTERNAL; EDEMA; EPIDERMAL GROWTH FACTOR; FEMALE; HUMANS; INFLAMMATION; MICE; MODELS, BIOLOGICAL; PEROXIDASE; PSORIASIS; RECOMBINANT PROTEINS;

EID: 0032995022     PISSN: 14222868     EISSN: None     Source Type: Journal    
DOI: 10.1159/000029848     Document Type: Article

References (21)

1. Camp RDR: Psoriasis; in Champion RH, Burton JL, Ebling FJG (eds): Textbook of Dermatology, ed 5. Oxford, Blackwell, 1992, pp 1391-1457.
2. Prigent SA, Lemoine NR: The type 1 (EGFR-related) family of growth factor and their ligands. Prog Growth Factor Res 1992;4:1-24.
3. 125I-epidermal growth factor binding and receptor distribution in psoriasis. J Invest Dermatol 1986;86:260-265.
4. Nanney LB, Yates RA, King LE: Modulation of epidermal growth factor receptor in psoriatic lesions during treatment with topical EGF. J Invest Dermatol 1992;98:296-301.
5. Nanney LB, Sundberg JP, King LE: Increased epidermal growth factor receptor in fsn/fsn mice. J Invest Dermatol 1996;106:1169-1174.
6. Poulsen SS: On the role of epidermal growth factor in the defense of gastroduodenal mucosa. Scand J Gastroenterol Suppl 1987;128:20-23.
7. Guglietta A, Sullivan PB: Clinical applications of epidermal growth factor. Eur J Gastroenterol Hepatol 1995;7:945-950.
8. Fretland DJ, Widomski DL, Zemaitis JM, Walsh R, Lewis S, Djuric S, Shone R, Tsai B, Gaginella T: Inflammation of guinea pig dermis. Effects of leukotriene B4 receptor antagonist SC-41930. Inflammation 1990;14:727-739.
9. Bradley PB, Priebat DA, Christensen RD, Rothstein G: Measurement of cutaneous inflammation. Estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982;78:206-209.
10. Renlund DG, McFarlane JL, Christensen RD, Lynch RE, Rothstein G: A quantitative and sensitive method for measurement of myeloperoxidase. Clin Res 1980;28:75A.
11. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
12. Gupta A, Fisher G, Elder J, Nickoloff B, Voorhees J: Sphingosine inhibits phorbol ester-induced inflammation, ornithine decarboxylase activity and activation of protein kinase C in mouse skin. J Invest Dermatol 1988;91:486-491.
13. Griffits RS, Wood BE, Li S, Blockham A: Pharmacological modification of 12-O-tetradecanoylphorbol-13-acetate induced inflammation and epidermal cell proliferation in mouse skin. Agents Actions 1988; 25:344-351.
14. 2α in the epidermis of psoriasis. Proc Natl Acad Sci USA 1975;72:5130-5134.
15. Duel EA, Ellis CN, Voorhees JJ: Determination of 5, 12 and 15 lipoxigenase products in keratomed biopsies of normal and psoriatic skin. J Invest Dermatol 1988;9:446-450.
16. Young LM, Spires DA, Bedord CJ, Wagner B, Ballaron SJ, De Young LM: The mouse ear inflammatory response to topical arachidonic acid. J Invest Dermatol 1984;84:367-371.
17. Ishii K, Motoyoshi S, Kawata J, Nakagawa H, Takeyama K: A useful method for differential evaluation of anti-inflammatory effects due to cyclooxygenase and 5-lipoxygenase inhibitions in mice. Jpn J Pharmacol 1994;65:297-303.
18. Berkenkop J, Casmer C, Watneck A: Drug activities in arachidonic acid and croton oil-induced inflammations. Agents Actions 1985;16: 601P.
19. Carlson RP, O'Neil-Davis L, Chang J, Lewis AL: Modulation of mouse ear oedema by cyclooxygenase and lipoxygenase inhibitors and other pharmacologic agents. Agents Actions 1985;17:197-204.
20. Opas EE, Robert MS, Bonney J, Humes JL: Prostaglandins and leukotriene synthesis in mouse ears inflamed by arachidonic acid. J Invest Dermatol 1985;84:253-258.
21. Tubaro A, Dri P, Melato M, Mulas G, Biachini P, Del Negro P, Della Loggia R: In the croton oil ear test the effect of non-steroidal anti-inflammatory drugs (NSAIDS) are dependent on the dose irritant. Agents Actions 1986;19:371-373.